Monday, December 23, 2024
HomeTagsS1P

S1P

Priothera Appoints Elisabeth Kueenburg M.D., as Chief Medical Officer

Priothera Ltd, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator compound, mocravimod, announces the appointment of Elisabeth Kueenburg, M.D.,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics